ABSTRACT
INTRODUCTION
Schizophrenia (MIM 181500) is a serious psychiatric disease that affects up to 1% of the population worldwide. (CANNON et al. 1998; JABLENSKY 2000) Studies have suggested that schizophrenia might result from a neurotransmission hypofunction of glutamatergic and N-methyl-D-aspartate (NMDA) receptors. (HALL et al. 2004; HARRISON and OWEN 2003; OWEN et al. 2004; RAPOPORT et al. 2005; TSAI and COYLE 2002) A number of studies have provided evidence of linkage scans and mapping to chromosome 13q22-q34. (BLOUIN et al. 1998; BRZUSTOWICZ et al. 1999; LEVINSON et al. 2000; LIN et al. 1997; SHAW et al. 1998) Chumakov et al. found robust evidence of genetic association within the 13q linkage region for schizophrenia. (CHUMAKOV et al. 2002) Two overlapping genes, G72 and G30, located at 13q34 spanning a 65 kb segment, have been shown to be significantly associated with schizophrenia using both individual single-nucleotide polymorphism (SNP) and haplotype analysis. (CHUMAKOV et al. 2002) G72 has been hypothesized to produce a protein PLG72, which is an agonist for the glycine-binding site of the NMDA glutamate receptors. (MOTHET et al. 2000) The postmortem analysis of schizophrenic patients has revealed overproduced G72 together with a lower NMDA glutamate receptor activity, which could result in glutamate signaling hypofunction. (CHUMAKOV et al. 2002) Further expression and functional studies have also supported the role of G72 in the etiology of schizophrenia. (CHUMAKOV et al. 2002; MOTHET et al. 2000; O'DONOVAN et al. 2003; SHIRTS and NIMGAONKAR 2004; TSAI and COYLE 2002) G72 protein interacts with the gene for D-amino acid oxidase (DAAO) on 12q24 to regulate glutaminergic signaling through the NMDA receptors pathway, (TSAI and COYLE 2002) variation within G72 could affect NMDA signaling through the functional pathway. (CHUMAKOV et al. 2002) The synergic effect on the risk for schizophrenia was higher than the effect of each individual gene due to the interaction between the proteins of G72 and DAAO. (CHUMAKOV et al. 2002) The story of G72/G30 is quite complex, as set out in an article by Detera-Wadleigh et al.(DETERA-WADLEIGH and MCMAHON 2006) G72/G30 is also believed to be associated with other psychiatric disorders, such as bipolar disorder. HATTORI et al. 2003; SCHUMACHER et al. 2004) Chumakov et al. (CHUMAKOV et al. 2002) initially reported strong associations between schizophrenia and dozens of single nucleotide polymorphisms (SNPs) in the G72/G30 and DAAO genes. The associations have been replicated independently in several, but not in all studies. The available evidence shows inconsistency with regard to which alleles show association with the disease. In an attempt to clarify this inconsistency and to measure the magnitude of the effect of the putative risk alleles the current meta-analysis has combined all available case-control and family-based association studies dealing with the G72/G30 and DAAO genes and schizophrenia.
METHODS

Literature search
The literature included in the analysis was selected using PubMed and focusing on the keywords "schizophrenia", "G72", "G30", "D amino acid oxidase", and "DAAO". All references cited in these studies and published reviews were examined in order to identify additional work not indexed by MEDLINE. The analyzed data covers those from all English-language publications up to October 2005.
Inclusion criteria
Eligible studies had to meet all of the following criteria: (1) they were published in peer-reviewed journals and were independent studies using original data, (2) they provided sufficient data to calculate the odds ratio (OR) with confidence interval and p value, (3) they investigated one or more of the 16 polymorphisms using either casecontrol or family-based approaches, (4) they described the genotyping primers, equipment and protocols used or provided reference to them, (5) they diagnosed schizophrenia patients according to the ICD, DSM or Chinese classification of mental disorders (CCMD) systems, and (6) they used healthy individuals as controls. Authors were contacted in cases where there were questions regarding their studies.
Quality assessments.
For association studies with inconsistent results based on the same polymorphisms, the methodological quality needs to be assessed using appropriate criteria to limit the risk of introducing bias into meta-analyses or systematic reviews. The classification method known as "Extended-Quality Score" was used to assess the quality of association studies. The extended-quality score categorises studies as being of 'high', 'medium', or 'poor' quality.
Statistical analyses
Any study which contained data from different ethnic populations (or genders) was considered effectively as several individual studies. Data from the case-control studies were summarized in two-by-two tables and transmission disequilibrium test (TDT) studies were summarized in two-by-one tables. From each table a log-odds ratio and its sampling variance were calculated. (CHO et al. 2005) Cochran's Chi-squared based Q statistic test was used to assess possible heterogeneity among the individual studies.
Heterogeneity Q tests were also performed to test for differences in OR between design types (case-control vs. family-based). A test for funnel plot asymmetry, described by Egger et al.,(EGGER et al. 1997 ) was used to assess evidence for publication bias. ORs were pooled using the method of DerSimonian and Laird, and 95% CIs were constructed using Woolf's method. The significance of the overall OR was determined by the Z-test. For the sensitivity analysis, each study was removed in turn from the total, and the remaining were reanalyzed. This procedure was used to ensure that no individual study was entirely responsible for a finding. The type I error rate was set at 0.05. P-values are two-tailed. An R-project program was used to depict the degree of differences and trend of association of risk allele frequency from controls to patients. If the vector (arrow) had the same direction this indicated the same kind of association, and vice versa.
Haplotype construction, counting, and linkage disequilibrium (LD) block defining were performed on 30 CEPH trios (Utah residents) using Haploview software (www.hapmap.org). The multiallelic D' was computed by performing a series of pairwise D' calculations using each haplotype in turn as an allele, with all other haplotypes at the locus serving as the other allele. This was then repeated for each haplotype at each locus and averaged by haplotype frequency. Maximum likelihood haplotype blocks were calculated using an EM algorithm.
RESULTS
The combined search yielded 49 references. After discarding overlapping references and those which clearly did not meet the criteria, 14 studies were retained. These studies were then filtered to ensure conformity with the inclusion criteria. For the G72/G30 genes, two studies HATTORI et al. 2003) were excluded because they were concerned with bipolar affective disorders other than schizophrenia; for the DAAO gene, one study (CHUMAKOV et al. 2002) was excluded on the grounds of insufficient data. Finally, 11 studies, consisting of 6 case-control (1292 cases and 1392 controls) (CHUMAKOV et al. 2002; KOROSTISHEVSKY et al. 2004; SCHUMACHER et al. 2004; WANG et al. 2004 ) and 3 TDT studies (ADDINGTON et al. 2004; MULLE et al. 2005; ZOU et al. 2005) for the G72/G30 genes, and 2 casecontrol studies (846 cases and 836 controls) (LIU et al. 2004; SCHUMACHER et al. 2004 ) for the DAAO gene, met our criteria for inclusion. The 11 studies included 2138 cases, 2228 controls and 463 parent-offspring trios. They all fell into the category of medium to high quality, with no study falling into the "poor" category For M12 of the G72/G30 genes, all studies showed a pooled p value of 0.02 (overall OR = 1.12 (1.02,1.24)) with evidence of heterogeneity between studies (p = 0.003) ( For M24, all studies showed a significant p value of 0.001 (overall OR = 0.8 (0.69,0.91)), and there was no evidence of heterogeneity (p = 0.64) (table 1). The forest plots for the four SNPs are shown in figure 1.
No statistically significant association was found in 9 other SNPs (table 1), and we found no significant association in the genotypic analyses for these SNPs whether the genotypes were combined with risk alleles or non-risk alleles (table 2) . 
DISCUSSION
As for the LD and haplotype structure, for the G72/G30 genes, the 13 polymorphisms, covering 4 bocks, were in two strong LD structures (figure 3). Furthermore, the M12 and M15 polymorphisms were located in one block, while M23 and M24 were in another strong block, which was consistent with results of the retrospective analysis.
For the DAAO gene, the three SNPs were in a strong LD block as we have described elsewhere. (LIU et al. 2004) Although previous individual studies have reported strong associations in the allelic, genotypic, or haplotypic analyses using either family-based or case-control method, the current meta-analysis only confirmed weak overall association with G72/G30, and there was considerable heterogeneity among the associated alleles. For most SNPs with heterogeneity, different alleles, genotypes or haplotypes seemed to be associated in different studies. Heterogeneity is partly due to possible sampling bias, including population stratification due to ethnicities and diagnostic variations or considerable differences in allele frequencies. Secondly, the G72/G30 genes may be under a complex expression control. It is likely that different regulatory elements respond to different cell types and developmental stages, and that different SNP Only one meta-analysis on G72 has previously been performed,(DETERA-WADLEIGH and MCMAHON 2006) and it combined data from different studies at the level of p-values. Compared with that study, the present meta-analysis uses more extensive statistical methods which can systematically incorporate information on specific alleles and genotypes. The present study, therefore, is a valuable addition to the literature on G72. However it has a number of limitations principle among which is that no real genotypes were available, which prevented comparison of haplotype frequencies. Other limitations include the possible effects of variables such as age, ethnicity, and gender, which can only be dealt with by using a greater range of studies. For subsequent meta-analyses, the sample size needed may depend on the degree of association, linkage disequilibrium, accuracy of phenotypic data, and heterogeneity of allelic frequencies. More accurate phenotype definition, strict selection of samples and uniformity of diagnosis and classification as well as use of standard demographical statistical methods would reduce the discrepancies and simplify collaboration and comparisons between studies.
Recent meta analyses covering international populations have pointed to glutamate-related genes such as the NRG1 (LI et al. 2006) and DTNBP1 (unpublished) as promising candidates for schizophrenia. It may be that these genes confer susceptibility to schizophrenia in interaction with one another, either in an epistatic or polygenic manner. Further investigations are required to identify if other at-risk polymorphisms within G72/G30 and DAAO confer a risk of schizophrenia and to clarify the role of the G72/G30 genes.
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